J&J Medical Connect
INVEGA HAFYERA®

(paliperidone palmitate 6-month)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Can I Receive INVEGA HAFYERA Treatment if I am Breastfeeding, Pregnant or Planning to Become Pregnant?

Last Updated: 07/07/2025

summary

Here is a passage from the INVEGA HAFYERA PATIENT INFORMATION which may be helpful to address your question:

Can I receive INVEGA HAFYERA if I am breastfeeding, pregnant, or planning to become pregnant?1:

  • It is not known if INVEGA HAFYERA will harm your unborn baby.
    • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with INVEGA HAFYERA.
    • If you become pregnant while receiving INVEGA HAFYERA, talk to your healthcare provider about registering with the National Pregnancy Registry for Atypical Antipsychotics. You can register by calling 1-866-961-2388 or visit http://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/.
    • Babies born to mothers who receive INVEGA HAFYERA during their third trimester of pregnancy may develop agitation, low muscle tone (floppy baby syndrome), tremors, excessive sleepiness, breathing problems, and feeding problems. Tell your healthcare provider right away if your baby develops any of these symptoms.
  • Before receiving INVEGA HAFYERA, tell your healthcare provider about all your medical conditions, including if you are breastfeeding or planning to breastfeed. INVEGA HAFYERA can pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with INVEGA HAFYERA.

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest use in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for INVEGA HAFYERA.1

References

1 INVEGA HAFYERA (paliperidone palmitate) extended-release injectable suspension [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INVEGA+HAFYERA-pi.pdf